ICPモニタリングデバイス市場：セグメント別規模、シェア、法規制、償還、手技、2036年までの予測

ICPモニタリングデバイスは、脳内圧亢進の原因となる神経学的状態の患者の頭蓋内圧（ICP）を測定するために使用される医療機器です。これらの神経学的状態には、外傷性脳損傷、くも膜下出血、水頭症、脳腫瘍などが含まれます。脳圧が上昇すると脳障害やその他の重篤な合併症を引き起こす可能性があるため、ICPのモニタリングは重要です。

外傷性脳損傷（TBI）はICPモニタリング装置使用の主な原因です。EVDを用いたICPモニタリングは、CSFドレナージという治療機能を追加できるため、ゴールドスタンダードと考えられています。EVDをICPモニタリングに使用することを制限する要因のひとつは、脳室サイズが小さい患者や脳腫脹のある患者にはEVDを挿入することが困難であることです。また、ICPモニタリングにEVDを長期間使用すると、頭蓋内感染のリスクが高まります。

当レポートは、世界のICPモニタリングデバイス市場について詳細に考察し、市場における競合情勢、SWOT分析、2036年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されているICPモニタリングデバイスと競合情勢

• 主要な業界動向の洞察
• ICPモニタリングデバイスのセグメント別総市場収益と2015年～2036年の市場展望
• 台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• ICPモニタリングデバイス市場のSWOT分析
• ICPモニタリングデバイス市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

ICP monitoring devices are medical devices used to measure intracranial pressure (ICP) in patients with neurological conditions that can cause increased pressure in the brain. These neurological conditions may include traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and brain tumors. Monitoring ICP is important because increased pressure in the brain can lead to brain damage and other serious complications.

Traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. ICP monitoring using an EVD is considered as the gold standard as the technique allows an additional therapeutic function of CSF drainage. One factor which limits the use of EVDs for ICP monitoring is the difficulty of inserting the device in patients with small ventricle size or in patients with brain swelling. Also, long term use of EVDs for ICP monitoring increases the risk of intracranial infection.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ICP Monitoring Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total ICP Monitoring Devices market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for ICP Monitoring Devices market.
• Competitive dynamics insights and trends provided for ICP Monitoring Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, Medtronic Plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, HpBio Proteses Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ICP Monitoring Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving ICP Monitoring Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ICP Monitoring Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ICP Monitoring Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.